Patents by Inventor Nicholas Lowther

Nicholas Lowther has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mixtures or Organic Compounds for the Treatment of Airway Diseases
    Publication number: 20120108555
    Abstract: A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.
    Type: Application
    Filed: January 9, 2012
    Publication date: May 3, 2012
    Inventors: Bernard Cuenoud, Robin Alec Fairhurst, Nicholas Lowther
  • MIXTURES OR ORGANIC COMPOUNDS FOR THE TREATMENT OF AIRWAY DISEASES
    Publication number: 20100068288
    Abstract: A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.
    Type: Application
    Filed: October 9, 2009
    Publication date: March 18, 2010
    Inventors: Bernard Cuenoud, Robin Alec Fairhurst, Nicholas Lowther
  • Mixtures or organic compounds for the treatment of airway diseases
    Patent number: 7622484
    Abstract: A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.
    Type: Grant
    Filed: October 12, 2005
    Date of Patent: November 24, 2009
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, Robin A Fairhurst, Nicholas Lowther
  • Mixtures or organic compounds for the treatment of airway diseases
    Publication number: 20060052352
    Abstract: A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.
    Type: Application
    Filed: October 12, 2005
    Publication date: March 9, 2006
    Inventors: Bernard Cuenoud, Robin Fairhurst, Nicholas Lowther
  • Mixtures or organic compounds for the treatment of airway diseases
    Patent number: 7008951
    Abstract: A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.
    Type: Grant
    Filed: August 4, 2004
    Date of Patent: March 7, 2006
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, Robin Alec Fairhurst, Nicholas Lowther
  • Mixtures or organic compounds for the treatment of airway diseases
    Publication number: 20050009795
    Abstract: A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.
    Type: Application
    Filed: August 4, 2004
    Publication date: January 13, 2005
    Inventors: Bernard Cuenoud, Robin Fairhurst, Nicholas Lowther
  • Mixtures for organic compounds for the treatment of airway diseases
    Patent number: 6800643
    Abstract: A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.
    Type: Grant
    Filed: June 4, 2003
    Date of Patent: October 5, 2004
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, Robin Alec Fairhurst, Nicholas Lowther
  • Organic compounds
    Publication number: 20040038951
    Abstract: A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.
    Type: Application
    Filed: June 4, 2003
    Publication date: February 26, 2004
    Inventors: Bernard Cuenoud, Robin Alec Fairhurst, Nicholas Lowther
  • Desferrioxamine-B salts and their use as orally effective iron chelators
    Patent number: 5739167
    Abstract: A salt of formula (I) where X denotes a group of formula (II), Y denotes a group of formula (III) and R denotes the residue of an aliphatic or cycloaliphatic sulphonic acid having at least 3 carbon atoms after removal of an --SO.sub.3 H group therefrom.
    Type: Grant
    Filed: November 30, 1994
    Date of Patent: April 14, 1998
    Assignee: Novartis Corporation
    Inventors: Nicholas Lowther, Ian Francis Hassan, Ian Timothy William Matthews
  • Desferrioxamine-B salts
    Patent number: 5663201
    Abstract: A salt of formula ##STR1## where X denotes a group of formula ##STR2## Y denotes a group of formula ##STR3## and R denotes the residue of an aliphatic or cycloaliphatic sulphonic acid having at least 3 carbon atoms after removal of a --SO.sub.3 H group therefrom.
    Type: Grant
    Filed: March 11, 1996
    Date of Patent: September 2, 1997
    Assignee: CIBA-GEIGY Corporation
    Inventors: Nicholas Lowther, Ian Francis Hassan, Ian Timothy William Matthews
  • Pharmaceutical compositions comprising hybrid .alpha.-interferon
    Patent number: 5609868
    Abstract: The present invention provides a stable aqueous solution of hybrid .alpha.-Interferon which contains as the stabilizer a buffer at a pH of from 3.0 to 5.0.
    Type: Grant
    Filed: August 10, 1994
    Date of Patent: March 11, 1997
    Assignee: Ciba-Geigy Corporation
    Inventors: Nicholas Lowther, John D. Allen, Colin Howes